Archives

by in
Entry Author Date Location
FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News 02/03/12 Boston
Infinity Drug Fails in Pancreatic Cancer Trial, Shares Fall 01/27/12 Boston
Why Biogen Idec Got Out of the Corporate VC Business 01/27/12 Boston
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers 01/27/12 Boston
Infinity Offers Hint Of Effect With Pancreatic Cancer Drug 01/20/12 Boston
Millennium: Takeda Acquires San Diego’s Intellikine for $190M Upfront 12/20/11 Boston
The Genetics Institute Impact: Some Great Memories and Photos 12/15/11 Boston
Infinity, Idera, Civitas, & More Boston-Area Life Sciences Headlines 12/02/11 Boston
Rib-X, Skyhook, Michael J. Fox Foundation & More Boston-Area Deals News 11/30/11 Boston
Infinity Pharmaceuticals Snags $50M Extension From Mundipharma 11/29/11 Boston
Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO 11/03/11 Boston
Sha Mi, Biogen Idec’s Neurology Ace, to Join “The Genetics Institute Impact” on Dec. 14 10/21/11 Boston
The Genetics Institute Impact: Join Mark Ptashne, Tom Maniatis & Gabe Schmergel on Dec. 14 10/11/11 Boston
Encouraged by Early Work on Anti-Cancer Drug, Intellikine Hires New Head for Clinical Trials 07/18/11 San Diego
ASCO Wrap-Up: The Skinny on Cancer News From All Corners of the U.S. 06/07/11 National
Ariad and Infinity to Reveal Data at ASCO, Excelimmune Gets $10.5M, Hologic Buys TCT, & More Boston-Area Life Sciences News 06/03/11 Boston
Infinity Dares to Think Big Against Pancreatic Cancer, Prepares to Show Early Results This Weekend 06/02/11 Boston
Calistoga Hands the Keys to Gilead, Bets It Can Make Cancer a Chronic Disease Like HIV 02/23/11 Seattle
Infinity Says Cash Stretches to 2014 01/07/11 Boston
Longwood Raises First Fund, Biogen Adds Executives, Boston Scientific Acquires Intellect, & More Boston-Area Life Sciences News 01/07/11 Boston
Mike Huckman, Former CNBC Reporting Ace, Joins Stellar Lineup at Boston’s War on Cancer 10/14/10 Boston
Where Will the Next Gleevec Come From? Xconomy Forum Looks At the Edge of Cancer R&D 10/05/10 Boston
What Is Boston Doing for the War on Cancer? Find Out at Xconomy Forum on October 20 08/25/10 Boston
How Novartis Got Its Vaccines Groove Back, Intellikine Gets a Drug Development Deal, Ambrx CEO Departs, & More San Diego Life Sciences News 07/15/10 San Diego
ThredUP Funded by New Micro VC Firm, Visterra Grabs $6M, Vivox Gets $2M From Peacock Equity, & More Boston-Area Deals News 07/14/10 Boston
After the Meltdown: Synta Pharma CEO Trumpets New Top Cancer Drug 07/12/10 Boston
AlloCure Arrives in New England, Merck Shutters Cambridge Research Site, Infinity Cuts Deal With Intellikine, & More Boston-Area Life Sciences News 07/09/10 Boston
Infinity Pharma, Intellikine Strike Deal to Make Cancer Drugs Against Hot Target 07/08/10 Boston
Biogen Idec Reaches Deal With Icahn, Ironwood CEO Shares IPO Strategy, Luke Maps out the Genetics Institute Diaspora, & More Boston-Area Life Sciences News 03/26/10 Boston
The Genetics Institute Alumni: Where Are They Now? 03/22/10 Boston
Page 2 of 4 « previous page · next page »